314 results
Thumbnail

001556 - Cofactor-induced LTP anaphylaxis

Thumbnail

001566 - Anaphylaxis to diethyltoluamide (DEET) containing insect repellent

Thumbnail

D1.162 - Selecting the right immunotherapy for Vespa velutina nigrithorax anaphylaxis: does one treatment fits all?

Thumbnail

D1.284 - Trends in Recurrent Anaphylaxis Triggered by Food, Drug, and Insect Allergies from 2015 to 2021: A Population-Based Retrospective Cohort Study Using the National Insurance Claims Database of Japan

Thumbnail

D3.195 - Reasons for declining venom immunotherapy and its burden on patients' daily lives

Thumbnail

D3.198 - Hymenoptera Venom Allergy: A Case Report on Safe Discontinuation After Five Years of Venom Immunotherapy

Thumbnail

D3.265 - Biphasic anaphylaxis secondary to polyethylene glycol in a pediatric patient: a case report

Thumbnail

D3.268 - Chronic Allergen Exposure Induces Accumulation of IgE Plasma Cells in the Lung, Leading to Local IgE Antibody Production

Thumbnail

D3.269 - Drug-Induced Anaphylaxis in Children: A Comparative Analysis of Inpatient vs. Outpatient Settings

Thumbnail

D3.270 - A novel workflow for cell metabolomics: impact of anaphylaxis in a human endothelial system

Thumbnail

D3.272 - Safety and Efficacy of Vancomycin and Other Antimicrobial Drug Desensitization in Pediatric Patients

Thumbnail

D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria

Thumbnail

D3.274 - Succesful Omalizumab Desensitization in Two Children with Severe Allergic Asthma and Cronic Spontaneous Urticaria

Thumbnail

D3.275 - Anaphylaxis caused by polyhexanide

Thumbnail

D3.276 - Acalabrutinib as premedication in platinum agents desensitization protocols: a case series supporting its role in enhancing tolerance with a repeatible efficacity

Thumbnail

D3.277 - Features of severe anaphylaxis in children, data from the Moscow Pediatric Register

Thumbnail

D3.278 - Cold urticaria: a case report

Thumbnail

D3.279 - Biomarkers in anaphylaxis

Thumbnail

D3.282 - Anaphylaxis to Gadoteric Acid: A Case Report

Thumbnail

D3.283 - Taming the Unpredictable: Omalizumab’s Role in Idiopathic anaphylaxis and chronic spontaneous urticaria